Related Experiment Video
Updated: Jan 20, 2026

Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation
Published on: July 20, 2022
Diagnosis and Management of Left Atrium Appendage Thrombosis in Atrial Fibrillation Patients Undergoing Cardioversion
Enrico Melillo1, Giuseppe Palmiero2, Adele Ferro3
1Department of Cardiology, AO dei Colli, Monaldi Hospital, 80131 Naples, Italy. doc.emelillo88@gmail.com.
Insights
Atrial fibrillation patients undergoing cardioversion need anticoagulation to prevent stroke. Transesophageal echocardiography helps detect left atrial appendage thrombus, guiding treatment decisions for safer rhythm restoration.
Area of Science:
- Cardiology
- Cardiac Electrophysiology
Background:
- Atrial fibrillation is the most common cardiac arrhythmia.
- It significantly increases stroke and thromboembolic complication risks.
- Rhythm control via cardioversion is recommended for symptomatic patients.
Purpose of the Study:
- To review left atrial appendage (LAA) thrombosis epidemiology and risk factors.
- To discuss the role of echocardiography in cardioversion decision-making.
- To evaluate anticoagulant efficacy in LAA thrombosis detection and treatment.
Main Methods:
- Literature review on atrial fibrillation, cardioversion, and LAA thrombosis.
- Analysis of echocardiography's role in pre-cardioversion assessment.
- Review of studies on anticoagulant therapy for LAA thrombosis.
Main Results:
- LAA thrombosis is a key concern before cardioversion, necessitating anticoagulation.
- Transesophageal echocardiography is crucial for excluding LAA thrombus.
- Anticoagulant regimens vary in efficacy for LAA thrombosis management.
Conclusions:
- Effective anticoagulation and echocardiographic assessment are vital for safe cardioversion in atrial fibrillation.
- Understanding LAA thrombosis risk factors and management is essential.
- Further research on optimal anticoagulant strategies is warranted.
Abstract:
Atrial fibrillation is the most common cardiac arrhythmia and is associated with an increased risk of stroke and thromboembolic complications. A rhythm control strategy with both electrical and pharmacological cardioversion is recommended for patients with symptomatic atrial fibrillation. Anticoagulant therapy for 3-4 weeks prior to cardioversion is recommended in order to avoid thromboembolic events deriving from restoring sinus rhythm. Transesophageal echocardiography has a pivotal role in this setting, excluding the presence of left atrial appendage thrombus before cardioversion. The aim of this review is to discuss the epidemiology and risk factors for left atrial appendage thrombosis, the role of echocardiography in the decision making before cardioversion, and the efficacy of different anticoagulant regimens on the detection and treatment of left atrial appendage thrombosis.
Related Concept Videos
Venous Thrombosis IV: Nursing Management
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid Fibrils
Surface Appendages of Archaea
Nursing Process for Patient and Caregiver Teaching I: Assessment and Diagnosis
It is critical to determine the patient's learning needs during the assessment. Determination of learning needs compounds data...
Venous Thrombosis I: Introduction

